| | |
ASPsiRNA information |
siRNA Id: | aspsirna3550
|
siRNA Name: | siA9/C8
|
Mismatch information |
Wild siRNA (As strand 3'->5'): | CACCGGUCCACCUUCAUUUUAG
|
ASP-siRNA (As strand 3'->5'): | CACCGGUGUACCUUCAUUUUAG
|
Mismatch position in siRNA: | U14C,G15C |
Gene Information |
Gene Name | Microtubule-associated protein tau (MAPT) |
Target Sequence (5'->3'): | GUGGCCAGGUGGAAGUAAAAUC
|
Wild allele (5'->3'): | GUGGCCAGGUGGAAGUAAAAUC
|
Mutant allele (5'->3'): | GUGGCCACAUGGAAGUAAAAUC
|
Position of siRNA on target gene: | 2274-2295
|
Respective Gene/Protein Resources |
GenBank Accession: | NM_016835.4 |
Cytogenic location: | 17q21.31 |
Chromosomal coordinates: | 17:43,971,701-44,105,699 |
UniProt ID: | P10636 |
HUGO ID: | 6893 |
Reference SNp(RefSNP): | rs63750570 |
Disease/Mutation information |
Target Mutation: | c.1960G>A,p.Val654Met
|
Matation type/variant: | Single nucleotide variant/Missense variant
|
Mutation at gene level: | NG_007398.1:g.129219G>A
|
Pathogenic status of mutation: | Disease causing
|
Disease: | Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) |
Clinical Resources |
ClinVar ID: | 14252 |
KEGG disease ID: | H00078 |
OMIM ID: | 600274 |
COSMIC: | MAPT |
DECIPHER: | MAPT |
GeneTests: | MAPT |
ASP siRNA details |
Mutant allele (5'->3'): | GUGGCCACAUGGAAGUAAAAUC
|
ASP-siRNA (As strand 3'->5'): | CACCGGUGUACCUUCAUUUUAG
|
Percentage efficacy of ASP-siRNA for mutant allele: | 65
|
Wild allele (5'->3'): | GUGGCCAGGUGGAAGUAAAAUC
|
ASP-siRNA (As strand 3'->5'): | CACCGGUGUACCUUCAUUUUAG
|
Percentage efficacy of ASP-siRNA for wild allele: | 0
|
Relative difference: | 65
|
Wild siRNA details |
Wild allele (5'->3'): | GUGGCCAGGUGGAAGUAAAAUC
|
Wild siRNA (As strand 3'->5'): | CACCGGUCCACCUUCAUUUUAG
|
Percentage efficacy of wild siRNA for wild allele: | 49
|
Wild allele (5'->3'): | GUGGCCAGGUGGAAGUAAAAUC
|
ASP-siRNA (As strand 3'->5'): | CACCGGUGUACCUUCAUUUUAG
|
Percentage efficacy of Wild sirna for mutant allele: | 20
|
Relative difference : | 29
|
General information |
Mismatch incorporated in siRNA/Target: | siRNA |
Cell-line used: | Cos-7 |
Experimental technique used: | Western blot |
Transfection method: | Lipofectamine Plus |
siRNA expression method: | Integrated DNA Technologies |
Post-transfection duration: | 24 hours |
Concentration used: | 2.5mg |
Reference: | US20080176812A1 |
Delivery method: | Adenovirus associated shRNA delivery |
'Article title: | Allele-specific silencing of disease genes. |
'Authors: | Davidson Beverly L, Harper Scott, Gonzalez-Alegre Pedro,Miller Victor, Paulson Henry |
'Journal Reference: | US2008/0176812 A1 |
'